C21 · Pharmaceuticals · China
Alzheimer's disease innovative drug clinical trial approvals (multi-year total)
China: 8 in 2023–2024.
- 8 Latest · China · 2023–2024
- Irregular Release cadence
- 1 Record · 1 region · 2023–2024
Verified 27 Sep 2026 · 1 publisher
The figure
One published observation so far. A chart follows as soon as a second period is published.
Alzheimer's disease innovative drug clinical trial approvals (multi-year total)
China, 2023–2024
Every record
1 record · 1 region · 2023–2024. Each period links to its record: the value, its source evidence and original document.
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: NMPA. Licence: CC BY 4.0.
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (NMPA); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Number of innovative drugs approved to initiate clinical trials for the treatment of Alzheimer's disease during the specified period.
- Measure
- One slice of Clinical trial approvals ( basis: cumulative, form: count, segment: alzheimers innovative ) . Total number of investigational new drug or clinical trial applications authorized by regulatory authorities. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 1 document
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Measures facilitate approval of 48 first-in-class innovative drugs | NMPA | — | 1 |
Frequently asked questions
What is the latest alzheimer's disease innovative drug clinical trial approvals (multi-year total)?
China: 8 in 2023–2024.
Where does this data come from?
From 1 document published by NMPA. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Irregularly: the publishers behind this measure do not release it on a fixed schedule. A new figure appears here once it is published and verified.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Alzheimer's disease innovative drug clinical trial approvals (multi-year total) [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/alzheimer-s-disease-innovative-drug-clinical-trial-approvals-multi-year-total
"Alzheimer's disease innovative drug clinical trial approvals (multi-year total)." StatOrigin, 2026, https://statorigin.org/indicators/alzheimer-s-disease-innovative-drug-clinical-trial-approvals-multi-year-total. Accessed 28 Oct. 2026.
StatOrigin. "Alzheimer's disease innovative drug clinical trial approvals (multi-year total)." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/alzheimer-s-disease-innovative-drug-clinical-trial-approvals-multi-year-total.
@misc{statorigin_alzheimer_s_disease_innovative_drug_clinical_trial_approvals_multi_year_total_2026, title = {Alzheimer's disease innovative drug clinical trial approvals (multi-year total)}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/alzheimer-s-disease-innovative-drug-clinical-trial-approvals-multi-year-total}, note = {Data set. Accessed 2026-10-28} }